Ketamine infusion trial offers hope for debilitating daily headaches
NCT ID NCT05306899
Summary
This study is testing if a single, high-dose intravenous (IV) ketamine infusion can reduce the frequency and severity of chronic daily headaches. About 56 participants will be randomly assigned to receive either the ketamine infusion or a saline (placebo) infusion. Researchers will measure how many headache days participants have, their pain levels, and their quality of life over three months to see if ketamine provides lasting relief.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC DAILY HEADACHE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Toronto Western Hospital
RECRUITINGToronto, Ontario, M5T 2S8, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Women's College Hospital
RECRUITINGToronto, Ontario, M5S 1B2, Canada
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.